Pharma Pulse 5/6/24: Tips to Rescue a Clinical Trial Before It’s Too Late, What You Need to Know About the UnitedHealth Hack & more

Tips to Rescue a Clinical Trial Before It’s Too Late

Why constant communication and transparency are paramount to successful partnerships between pharmaceutical companies and CROs.

Specialty Pharmacies Drive Cost Savings in Value-Based Care | Asembia 2024

Managed Healthcare Executive editors spoke with Bill McElnea, vice president of population health at Shields Health Solutions, about specialty pharmacies reducing costs for patients at the 2024 Asembia Specialty Pharmacy Summit in Las Vegas.

UnitedHealth Hack: What You Need to Know

Key questions remain after UnitedHealth CEO Andrew Witty testified in two Congressional hearings on May 1

FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV

Gilead Sciences, Inc. announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg tablets, B/F/TAF) to treat pregnant people with HIV-1 (PWH) with suppressed viral loads.

Slope on LinkedIn:

The "first mile," which encompasses the collection of patient samples at the site to their reception at various labs, is the starting point for ensuring trial data accuracy and completion. So, why do we still commonly see problems with sample collection, tracking, and reconciliation during this period?

Our Vice President of Scientific Operations and Development, Mark Melton, MSc, discusses this challenge and its potential solutions in the Q&A below. A huge thank you to Pharmaceutical Executive for sharing his perspective!

#clinicalresearch #thefirstmile #siteoperations #samplemanagement

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs